Rajkumar Ganesan

Rajkumar Ganesan

Company: Janssen R&D

Job title: Director, Biologics Discovery

Seminars:

Next-Generation Immunotherpeutics – Selective Recruitment of γδ T Cells by Bispecific Antibodies 4:30 pm

• Immunotherapeutic approaches for redirecting pan CD3+ T cells to target cancer is under clinical investigation • Prototypic bispecific antibody concurrently binds to the Vγ9 chain of the Vγ9Vδ2+γδT cells and to tumor antigens for efficient lysis of tumor cells (in vitro and in vivo). • Bispecific antibodies selectively activates Vγ9+ γδ T cells and…Read more

day: Day One

Panel Discussion 4:00 pm

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.